Introduction

Epstein-Barr virus (EBV) infection is implicated in the development
2-6
Classical Hodgkin's lymphoma is characterized by the presence of multinucleated, malignant
Hodgkin/Reed-Sternberg (HRS) cells, which constitute only a minority of the tumor cells. 7 HRS cells are presumed to derive from germinal center B cells that have lost expression of immunoglobulin (Ig) and other B cell-specific characteristics. [7] [8] [9] It has been estimated that nearly half of all Hodgkin's lymphomas contain EBV DNA and viral gene expression appears to be limited to EBNA1, LMP1, and LMP2A. 2, [10] [11] [12] The consistent detection of LMP2A transcripts in both tumor cells and latently infected B cells in vivo suggests that LMP2A plays an important role in viral persistence and in the development of EBVassociated diseases such as Hodgkin's lymphoma.
In latently infected lymphocytes, LMP2A localizes to small glycolipid-enriched microdomains in the plasma membrane, where it is thought to mimic an activated B cell receptor (BCR). 13, 14 Studies demonstrate that BCR activation in LMP2A-expressing cells fails to induce calcium mobilization and activation of the downstream signaling molecules Lyn, Syk, phosphatidylinositol 3-kinase (PI3-K), phospholipase C-2 (PLC 2), Vav, Shc and mitogen-activated protein kinase (MAPK). 15, 16 The aminoterminal domain of LMP2A is tyrosine phosphorylated and associates with Src family protein tyrosine kinases (PTKs) as well as Syk. 16, 17 Mutational analyses indicate that phosphotyrosines at positions 74 and
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All three residues are essential for the LMP2A-mediated block in BCR signal transduction. 18, 19 Expression of a LMP2A transgene in vivo interferes with normal B cell development, allowing BCR-negative cells to exit the bone marrow and colonize peripheral lymphoid organs. 20 Bone marrow B cells from these mice undergo Ig light chain, but not heavy chain gene rearrangement, indicating that LMP2A signaling bypasses the requirement for Ig recombination and allows IgM negative cells, which would normally undergo apoptosis, to colonize peripheral lymphoid organs. 20 Furthermore, bone marrow cells from LMP2A transgenic mice form colonies in IL-7-containing methylcellulose and the B cells in these colonies lack IgM expression, indicating that LMP2A bypasses the requirement for Ig rearrangement and allows for IL-7-driven B cell proliferation. 20, 21 The LMP2A-mediated effects on B cell development and survival in vivo have been shown to require the ITAM (Syk binding). 22 In addition, studies utilizing mice deficient for the downstream B cell signaling components BLNK (SLP-65) or Bruton's tyrosine kinase (Btk) have demonstrated that LMP2A utilizes these molecules for its effects on B cell development and survival. 23, 24 In a recent study, we utilized DNA microarray technology to identify alterations in gene expression in B cells from mice expressing the LMP2A transgene. We identified not only decreased expression of genes associated with normal B cell development, but also reduced levels of the transcription factors that regulate expression of those genes. 25 These results suggest that LMP2A induces a global down-regulation of gene transcription necessary for proper B cell development. In this study, we present the complete results of our microarray analyses of B cells from LMP2A trangenic mice and include a comparison of gene transcription in human B cell lines expressing LMP2A as well as LMP2A-positive and -negative EBV-infected lymphoblastoid cell lines (LCLs). These experiments have identified common pathways affected by LMP2A in both murine in vivo and human in vitro systems and have provided further relevance with regard to the role of LMP2A in the development of EBV-associated Hodgkin's lymphoma. 
Materials and methods
Isolation of primary B cells from mice
Construction and characterization of the Eµ TgE LMP2A transgenic mice have been described previously. 20 All animals were housed at the Northwestern University Center for Experimental Animal
Resources in accordance with university animal welfare guidelines. 
Cell lines
All cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 1000 U/ml penicillin, and 1000 µg/ml streptomycin. The BJAB cell line is an established EBV-negative B lymphoma line (ATCC, Rockville, MD). BJAB cell lines expressing LMP2A were generated by retrovirus infection as previously described. 26 Gene expression was compared in two individual BJAB clones that contain vector alone (C1 and F6) and two clones that express LMP2A (C12 and F11). The EBV-infected
LCLs have been described previously. 27 Lines LCL1 and LCL2 are EBV+LMP2A+ and lines ES2 and ES5 are EBV+LMP2A-LCLs. 
RNA preparation and microarray experiments
Total RNA was extracted from CD19+ murine B cells and human cell lines according to the Trizol reagent protocol (Invitrogen, Carlsbad, CA). RNA was then subjected to cleanup using the Qiagen Rneasy Mini Kit according to the RNA cleanup protocol (Qiagen, Valencia, CA). Aliquots of RNA were then removed and run on 1% agarose/formaldehyde gels to verify that no degradation occurred. Additionally, OD readings were taken and 20 µg of total RNA having OD A 260 /A 280 readings between 1.9 and 2.1 was utilized for reverse transcription. Double-stranded cDNA was then generated according to the Superscript Double-Stranded cDNA Synthesis Kit (Invitrogen, Carlsbad, CA) using an oligo dT/T7 primer (5'-GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-(dT) 24 University. The murine genome U74A and human U133A chips were purchased from Affymetrix (Santa Clara, CA) and utilized for analysis.
Statistical significance of differential expression
Affymetrix microarrays were used to quantify expression in all experiments. The Affymetrix system of expression quantification using perfect and mismatched olionucleotides was used in conjunction with the system of background detection. At least two separate, identical experiments comparing gene transcription Northwestern University, performed statistical analyses of the arrays. A t-distribution was applied to the difference between LMP2A-expressing and control cells. The t-test quantifies the probability of differential expression through calculation of the magnitude and consistency of changes. Genes with probability values greater than .01 were deemed to be inconsistent, therefore statistically insignificant. For Tables 1, 2 , 5, and 6, expressed sequence tags with no known homology or function were excluded and the selected data were placed into categories based on protein function. 
Results
Overall changes in gene expression induced by LMP2A in murine cells in vivo
In order to identify the molecular basis for the B cell abnormalities observed in LMP2A transgenic mice, 
Categorization of genes affected by LMP2A
In order to further define the effects of LMP2A in B cells, genes identified from each microarray were placed into categories based on protein function. Those genes with unknown function or whose category placement was unclear were designated as other/unknown. Figure 1B 
Genes altered by LMP2A
Genes in which transcription was altered by LMP2A expression in murine and human B cells are listed in Tables 1 (increased) and 2 (decreased). These tables contain only the categories of genes that we believe may be associated with the development of EBV-associated malignancies. Tables 5 and 6 list the genes contained in the remaining categories and are included as supplemental information. It is possible that genes listed in the supplemental tables may also contribute to EBV-associated pathologies; however, it was necessary to limit the amount of information presented to the focus of this article.
One category of genes in which expression was altered by LMP2A included those encoding proteins involved in cell cycle induction and inhibition of apoptosis. Expression of many cell cycle genes was increased by LMP2A, including Cyclin D1, Cdk5, Cdk9 (bone marrow); Cdc20, Cdc2a, (LCL) . Genes encoding anti-apoptotic proteins were also increased by LMP2A, including Survivin (bone marrow and spleen) and Api6, Bcl-xL (spleen). Expression of many negative regulators of cell cycle induction was inhibited by LMP2A, including Bin1 (bone marrow and spleen); Btg2 (spleen); Btg3 (BJAB); and Bcaa, Rb1 (LCL)( Table 2 ).
In addition, expression of various pro-apoptotic genes was decreased, including Caspase 6, Ubcr (bone marrow); P53 (spleen); Pdcd4, Ucrq (BJAB); and Atm, Pten (LCL). These results indicate that LMP2A alters gene transcription to favor cell cycle induction and inhibition of apoptosis, either of which may contribute to the development of B cell lymphoma.
As mentioned previously, transcription of many genes involved in DNA and RNA metabolism was altered by LMP2A expression. In both the murine primary B cells and the human B cell lines, LMP2A expression resulted in increased expression of genes involved in chromatin modification, DNA replication, and RNA transcription/translation. These genes encode various types of proteins, including histones, zinc finger proteins, helicases, polymerases, eukaryotic translation factors, ribosomal proteins, and tRNA synthetases (Table 1A) (Table 1A) . In addition to splicing factors, the LMP2A-expressing BJABs and LCLs expressed increased levels of genes encoding the Swi-Snf and Baf53 chromatin remodeling components, respectively. LMP2A expression in primary murine B cells and/or human B cell lines resulted in decreased expression of genes encoding histones, polymerases, zinc finger proteins, Rad family proteins, heterogeneous nuclear ribonucleoproteins, and ribosomal proteins ( Table 2 ). In addition, (Table 1B) . Although the exact function of many of these genes is unknown, expression of each has been shown to exhibit a strong correlation with malignant development. Interestingly, expression of genes encoding components of the proteosome complex was upregulated by LMP2A in all cell types tested (Table 1B) . We have previously shown that LMP2A associates with Nedd4 family ubiquitin ligases and that this association results in the internalization and degradation of LMP2A and its associated proteins; therefore, it is intriguing that LMP2A appears to also induce transcription of the ubiquitination components as well. (Table 4) . Similarly, decreased expression of genes encoding immunological factors (Ifn-r2, IgD,
LMP2A-expressing human cell lines exhibited decreased expression of eukaryotic translation factors
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Shp, Ccr1, Ccr6, Cd69) was observed in LMP2A-expressing cells and centroblasts (Table 4) (Table 2) . One reason for these differences may be that the LCLs were generated by immortalization of primary B cells in vitro by EBV infection. In contrast, the BJAB cell line is an established, immortalized line that contains pre-existing alterations in genes important for cell survival. It is likely that LMP2A-mediated transcriptional alterations would more closely resemble those in primary murine B cells and LCLs following BCR ligation in BJABs since alterations in downstream BCR signaling events in LMP2A-expressing BJABs have been clearly documented. 14, 16 Although the specific genes affected by LMP2A were different in the various cell types analyzed, they were often functionally similar, suggesting that LMP2A targets specific cellular pathways. 
It is intriguing that transcriptional changes similar to those demonstrated in LMP2A-expressing cells have been described in HRS cells of Hodgkin's lymphoma, particularly genes involved in cell cycle induction, apoptosis inhibition, and supression of cell-mediated immunity (Table 3 and Figure 2 ). These correlations not only implicate a role for LMP2A in the development of Hodgkin's lymphoma, but provide further insight into the mechanisms utilized by LMP2A to establish viral latency in peripheral B cells. By allowing EBV-infected cells to avoid immune recognition and apoptosis induction, LMP2A is able to successfully establish and maintain viral latency. In addition, it has been well documented that Hogdkin's lymphoma cells utilize various strategies to mediate immune evasion. 34 The results of this study also indicate that LMP2A may be involved in the down-regulation of many B cell specific factors in HRS cells, which has made it difficult to determine the cellular origin of these cells until recently. 7, 9 It is important to note that many of the transcriptional abnormalities discussed here have been documented in EBV-negative as well as EBV-positive HRS cells. In fact, no clear correlation has been found between the expression of many of these genes and the EBV status of the HRS cells analyzed. This would suggest that a factor other than LMP2A may be responsible for altered gene regulation in EBV-negative HRS cells. However, it is possible that these cells were initially infected with EBV, but have lost viral gene expression during the late stages of malignant development. Additionally, it has been suggested that EBV-negative HRS cells may contain an as yet unidentified infectious agent, which may express a functionally homologous protein to LMP2A. 35 Finally, altered gene expression in EBV-negative HRS cells may be due to a spontaneous genetic event that duplicates the effects of LMP2A.
An additional, striking correlation was made between transcriptional alterations in LMP2A-expressing cells and activated, proliferating germinal center centroblasts, particularly increased expression of genes involved in cell cycle induction and DNA metabolism and decreased expression of immunological factors ( (Tables 2 and 6 ). NF-B activation has been shown to be required not only for proliferation and survival of peripheral B cells 38 , but more specifically for proliferation and survival of HRS cells. 39, 40 Therefore, LMP2A may be able to upregulate the expression of cell cycle and survival genes through activation of the NF-B pathway, similar to LMP1. LMP2A also appears to affect the transcription of genes that are normally regulated by the Ras signaling pathway, which may provide another mechanism for increased cell survival.
Microarray data from LMP2A-expressing cells were also compared to analyses involving B cells transformed with v-abl, which blocks B cell development. 41 Many similarities were identified, including been correlated with cell proliferation and survival in Hodgkin's lymphoma and is proposed to be a contributing factor to the lack of B cell specific gene transcription in HRS cells. 42 The effects of LMP2A on each of these cellular pathways should be further studied to elucidate the molecular mechanisms utilized by LMP2A to maintain viral latency and contribute to the development of human malignancies.
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